Authors:
AYDINOK Y
COKER C
KAVAKLI K
POLAT A
KANTAR M
NISLI G
CETINGUL N
CETINER N
Citation: Y. Aydinok et al., URINARY ZINC EXCRETION AND ITS ASSOCIATION WITH RENAL TUBULER CELL DYSFUNCTION IN BETA-THALASSEMIA MAJOR, British Journal of Haematology, 102(1), 1998, pp. 53-53
Authors:
KAVAKLI K
OZACAR T
POLAT A
ZEYTINOGLU A
AYDINOK Y
KANTAR M
NISLI G
BILGIC A
CETINGUL N
Citation: K. Kavakli et al., HUMAN PARVOVIRUS-B-19 SEROPREVALANCE IN TURKISH HEMOPHILIAC CHILDREN, British Journal of Haematology, 102(1), 1998, pp. 96-96
Authors:
CETINGUL N
ONIZ H
YILMAZ D
KANTAR M
KAVAKLI K
AYDINOK Y
POLAT A
NISLI G
OZTOP S
Citation: N. Cetingul et al., SERUM ERYTHROPOIETIN LEVELS AND RECOMBINANT-HUMAN-ERYTHROPOIETIN USE FOR ANEMIA IN CHILDREN WITH CANCER, British Journal of Haematology, 102(1), 1998, pp. 336-336
Authors:
SENER RN
YALMAN O
CETINGUL N
TUTUNCUOGLU S
KAVAKLI K
USTUN EE
Citation: Rn. Sener et al., DYSOSTEOSCLEROSIS - CLINICORADIOLOGIC FINDINGS INCLUDING BRAIN MRI, Computerized medical imaging and graphics, 21(6), 1997, pp. 355-357
Authors:
NISLI G
KAVAKLI K
AYDINOK Y
OZTOP S
CETINGUL N
Citation: G. Nisli et al., TERMINATION OF TRANSFUSION DEPENDENCE IN BETA-THALASSEMIA - 2-YEAR EXPERIENCE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN, Pediatric hematology and oncology, 14(3), 1997, pp. 285-287
Authors:
KAVAKLI K
NISLI G
AYDINOK Y
OZTOP S
CETINGUL N
AYDOGDU S
YALMAN O
Citation: K. Kavakli et al., PROPHYLACTIC THERAPY FOR HEMOPHILIA IN A DEVELOPING-COUNTRY, TURKEY, Pediatric hematology and oncology, 14(2), 1997, pp. 151-159
Authors:
NISLI G
KAVAKLI K
AYDINOK Y
OZTOP S
CETINGUL N
Citation: G. Nisli et al., SERUM ERYTHROPOIETIN LEVELS IN PATIENTS WITH BETA-THALASSEMIA MAJOR AND INTERMEDIA, Pediatric hematology and oncology, 14(2), 1997, pp. 161-167
Authors:
KUTUKCULER N
VERGIN C
KAVAKLI K
CETINGUL N
OZTOP S
NISLI G
CAGLAYAN S
Citation: N. Kutukculer et al., SPECIFIC ANTIBODY-RESPONSE IN CHILDREN WITH THALASSEMIA MAJOR, Pediatric hematology and oncology, 14(2), 1997, pp. 181-183
Authors:
NISLI G
KAVAKLI K
AYDINOK Y
OZTOP S
CETINGUL N
Citation: G. Nisli et al., BETA-THALASSEMIA ALLELES IN AEGEAN REGION OF TURKEY - EFFECT ON CLINICAL SEVERITY OF DISEASE, Pediatric hematology and oncology, 14(1), 1997, pp. 59-65
Authors:
KUTUKCULER N
VERGIN C
CETINGUL N
KAVAKLI K
CAGLAYAN S
OZTOP S
NISLI G
Citation: N. Kutukculer et al., PLASMA INTERLEUKIN-3 (IL-3) AND IL-7 CONCENTRATIONS IN CHILDREN WITH HOMOZYGOUS BETA-THALASSEMIA, Journal of tropical pediatrics, 43(6), 1997, pp. 366-367
Authors:
NISLI G
KAVAKLI K
AYDINOK Y
OZTOP S
CETINGUL N
BASAK N
Citation: G. Nisli et al., RECOMBINANT ERYTHROPOIETIN TRIAL IN CHILDREN WITH TRANSFUSION-DEPENDENT HOMOZYGOUS BETA-THALASSEMIA, Acta haematologica, 98(4), 1997, pp. 199-203
Authors:
KAVAKLI K
NISLI G
CETINGUL N
OZTOP S
BILGIC A
OZACAR T
Citation: K. Kavakli et al., HEPATITIS-B VACCINATION IN CHILDREN WITH THALASSEMIA, HEMOPHILIA AND CANCER, The Pediatric infectious disease journal, 15(12), 1996, pp. 1140-1141
Authors:
KUTUKCULER N
KUTLU O
NISLI G
OZTOP S
CETINGUL N
CAGLAYAN S
Citation: N. Kutukculer et al., ASSESSMENT OF NEUTROPHIL CHEMOTAXIS AND RANDOM MIGRATION IN CHILDREN WITH THALASSEMIA MAJOR, Pediatric hematology and oncology, 13(3), 1996, pp. 239-245
Authors:
KAVAKLI K
CETINGUL N
OZTOP S
NISLI G
OZACAR T
Citation: K. Kavakli et al., COMBINED ADMINISTRATION OF HEPATITIS-B VACCINE AND HEPATITIS-B IMMUNEGLOBULIN IN CHILDREN WITH CANCER, Pediatric hematology and oncology, 13(3), 1996, pp. 295-296
Authors:
CETINGUL N
KAVAKLI K
VERGIN C
OZTOP S
NILI G
AYDODU S
OZACAR T
BILGIC A
YUCE G
YACI R
Citation: N. Cetingul et al., ALPHA-INTERFERON-2B TREATMENT FOR CHRONIC HEPATITIS-B INFECTION IN CHILDREN WITH CANCER, Journal of tropical pediatrics, 42(5), 1996, pp. 262-266